Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ovaryl is a polyherbal Ayurvedic formulation developed and marketed by Mercury Laboratories for the management of polycystic ovarian syndrome (PCOS) and related ovulation disorders. It is a comprehensive non-hormonal preparation containing multiple herbal ingredients, including Dashmool and Triphala. The formulation is designed to correct hormonal imbalances, reduce ovarian volume, and lower serum insulin levels. Clinical evidence suggests that Ovaryl treatment improves menstrual regularity, promotes ovulation, and reduces symptoms such as hirsutism. It is available in both tablet and syrup forms and is positioned as a safer alternative to synthetic hormonal treatments for women's healthcare.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ovaryl.